Managed Account Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$42.7M Sell
312,238
-87,697
-22% -$10.9M 0.04% 450
2015
Q1
$49.8M Sell
399,935
-127,204
-24% -$13.5M 0.04% 408
2014
Q4
$47.7M Sell
527,139
-16,383
-3% -$1.36M 0.05% 411
2014
Q3
$39.2M Sell
543,522
-318,358
-37% -$20.9M 0.04% 447
2014
Q2
$53.6M Sell
861,880
-477,643
-36% -$28.9M 0.06% 354
2014
Q1
$91.4M Buy
1,339,523
+410,825
+44% +$30.3M 0.12% 209
2013
Q4
$65.3M Buy
928,698
+243,904
+36% +$16.6M 0.09% 270
2013
Q3
$49.4M Buy
684,794
+161,390
+31% +$10.7M 0.07% 308
2013
Q2
$29.2M Buy
+523,404
New +$32.6M 0.05% 437

Other funds holding BMRN